Annual CFO
-$37.56 M
-$11.10 M-41.95%
December 31, 2023
Summary
- As of February 8, 2025, TARA annual cash flow from operations is -$37.56 million, with the most recent change of -$11.10 million (-41.95%) on December 31, 2023.
- During the last 3 years, TARA annual CFO has fallen by -$14.15 million (-60.45%).
- TARA annual CFO is now -649.49% below its all-time high of -$5.01 million, reached on December 31, 2019.
Performance
TARA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.43 M
-$747.00 K-9.72%
September 30, 2024
Summary
- As of February 8, 2025, TARA quarterly cash flow from operations is -$8.43 million, with the most recent change of -$747.00 thousand (-9.72%) on September 30, 2024.
- Over the past year, TARA quarterly CFO has dropped by -$1.87 million (-28.55%).
- TARA quarterly CFO is now -124.19% below its all-time high of -$3.76 million, reached on September 30, 2020.
Performance
TARA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$35.20 M
-$1.87 M-5.62%
September 30, 2024
Summary
- As of February 8, 2025, TARA TTM cash flow from operations is -$35.20 million, with the most recent change of -$1.87 million (-5.62%) on September 30, 2024.
- Over the past year, TARA TTM CFO has dropped by -$1.32 million (-3.89%).
- TARA TTM CFO is now -392.58% below its all-time high of -$7.15 million, reached on March 31, 2020.
Performance
TARA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TARA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.0% | -28.6% | -3.9% |
| 3 y3 years | -60.5% | -28.6% | -3.9% |
| 5 y5 years | -61.6% | -28.6% | -3.9% |
TARA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.0% | at low | -67.8% | +34.6% | -33.0% | +6.3% |
| 5 y | 5-year | -649.5% | at low | -124.2% | +34.6% | -392.6% | +6.3% |
| alltime | all time | -649.5% | at low | -124.2% | +34.6% | -392.6% | +6.3% |
Protara Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.43 M(+9.7%) | -$35.20 M(+5.6%) |
| Jun 2024 | - | -$7.69 M(-25.9%) | -$33.33 M(-4.9%) |
| Mar 2024 | - | -$10.38 M(+19.3%) | -$35.05 M(-6.7%) |
| Dec 2023 | -$37.56 M(+42.0%) | -$8.70 M(+32.6%) | -$37.56 M(+10.8%) |
| Sep 2023 | - | -$6.56 M(-30.3%) | -$33.88 M(+3.7%) |
| Jun 2023 | - | -$9.41 M(-27.0%) | -$32.67 M(+15.1%) |
| Mar 2023 | - | -$12.89 M(+156.4%) | -$28.38 M(+7.3%) |
| Dec 2022 | -$26.46 M | -$5.03 M(-6.0%) | -$26.46 M(-6.6%) |
| Sep 2022 | - | -$5.35 M(+4.4%) | -$28.34 M(-2.9%) |
| Jun 2022 | - | -$5.12 M(-53.3%) | -$29.19 M(-13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.96 M(+58.7%) | -$33.54 M(-2.8%) |
| Dec 2021 | -$34.50 M(+47.4%) | -$6.91 M(+11.4%) | -$34.50 M(+0.4%) |
| Sep 2021 | - | -$6.20 M(-34.5%) | -$34.36 M(+7.6%) |
| Jun 2021 | - | -$9.47 M(-20.5%) | -$31.92 M(+13.3%) |
| Mar 2021 | - | -$11.92 M(+76.2%) | -$28.18 M(+20.4%) |
| Dec 2020 | -$23.41 M(+367.1%) | -$6.77 M(+79.9%) | -$23.41 M(+40.7%) |
| Sep 2020 | - | -$3.76 M(-34.4%) | -$16.64 M(+29.2%) |
| Jun 2020 | - | -$5.73 M(-19.8%) | -$12.88 M(+80.2%) |
| Mar 2020 | - | -$7.15 M | -$7.15 M |
| Dec 2019 | -$5.01 M(-78.4%) | - | - |
| Dec 2018 | -$23.23 M | - | - |
FAQ
- What is Protara Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Protara Therapeutics?
- What is Protara Therapeutics annual CFO year-on-year change?
- What is Protara Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Protara Therapeutics?
- What is Protara Therapeutics quarterly CFO year-on-year change?
- What is Protara Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Protara Therapeutics?
- What is Protara Therapeutics TTM CFO year-on-year change?
What is Protara Therapeutics annual cash flow from operations?
The current annual CFO of TARA is -$37.56 M
What is the all time high annual CFO for Protara Therapeutics?
Protara Therapeutics all-time high annual cash flow from operations is -$5.01 M
What is Protara Therapeutics annual CFO year-on-year change?
Over the past year, TARA annual cash flow from operations has changed by -$11.10 M (-41.95%)
What is Protara Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TARA is -$8.43 M
What is the all time high quarterly CFO for Protara Therapeutics?
Protara Therapeutics all-time high quarterly cash flow from operations is -$3.76 M
What is Protara Therapeutics quarterly CFO year-on-year change?
Over the past year, TARA quarterly cash flow from operations has changed by -$1.87 M (-28.55%)
What is Protara Therapeutics TTM cash flow from operations?
The current TTM CFO of TARA is -$35.20 M
What is the all time high TTM CFO for Protara Therapeutics?
Protara Therapeutics all-time high TTM cash flow from operations is -$7.15 M
What is Protara Therapeutics TTM CFO year-on-year change?
Over the past year, TARA TTM cash flow from operations has changed by -$1.32 M (-3.89%)